Dr. Bobak Parang Announced as Recipient of Rising Tide/LUNGevity Research Award for Overcoming Drug Resistance

The Quick Take
$600K+ investment leverages combination of FDA approved treatments to overcome drug resistance in EGFR-positive lung cancer WASHINGTON, Oct. 28, 2026 /PRNewswire/ -- A groundbreaking clinical trial aimed at overcoming drug resistance in EGFR-positive non-small cell lung cancer (NSCLC),...
Ground Level News gathers headlines from public news feeds. This page shows a short summary only; the full article and all rights belong to PR Newswire.


